Medtronic plc.

Open: 88.84 Close: 88.9 Change: 0.06

Are you still looking for information about Medtronic plc.? An AI summarized it for you.

This document will help you to evaluate Medtronic plc. without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Medtronic plc. are: Medtronic, Medtronics, hold, price, share, stock, company, …

Concept Map

Semantic Network

Stock Summary

Medtronic plc develops, manufactures, and sells device-based medical therapies. Cardiovascular, medical, surgical, and Neuroscience Portfolio segments offer products for spinal surgeons, neurosurgeons, neurologists, neurologist, pain management.

Today's Summary

Medtronic PLC stock underperforms Tuesday when compared to competitors. The current stock price is $89.41, suggesting Medtronics is undervalued at the current price. Longview Partners (Guernsey) Ltd. holds shares valued at 517M.

Today's News

Medtronic to announce financial results for its fourth quarter and full fiscal year 2023. Medtronics to host a video webcast at 7:00 a.m. Central Daylight Time (CDT) and will be available at https://://://www.medtronic.com. Medtronic PLC stock underperforms Tuesday when compared to competitors - MarketWatch. Shares of Medtronics PLC MDT, -0.46% shed 0.46%. Medtronic plc (NYSE:MDT) is a favorite amongst institutional investors who own 84% of the company. The top 25 shareholders own 50% of Medtronics. The general public, who are usually individual investors, hold a 16% stake in Medtron. Medtronic has a long history of innovation and market leadership in medical devices. The current stock price is $89.41, suggesting Medtronics is undervalued at the current price. Longview Partners (Guernsey) Ltd. holds Medtronics shares valued at 517M. Among the largest hedge funds holding Medtronic share is Longview. Partners (Gernsey), Ltd. It holds shares of 517 million. Medtronic introduced AccuRhythm™ AI algorithms in 2022 to patients and clinicians in Australia, countries throughout Europe, the United States, and New Zealand. The two AI algorithms have been shown to reduce the number of false alerts by as much as 84%, saving clinicians approximately 319 hours. Medtronic is one of the worlds leading medical technology companies known for its production and marketing of device-based medical therapies and services meant to improve patients lives. Foyston Gordon & Payne Inc holdings in Medtronics were worth $12,559,000. Since December 1, 1998, Medtronic plc.s market cap has increased from $33.29B to $118.27B, an increase of 255.33% Since then, the companys market cap is now $88.90. Medtronic is seeking a Clinical Territory Manager to support the education and training of the companys products to Health Care Professionals and patients. The position can reside in any of our US Medtronics office locations. Medtronic trades on the NYSE under the ticker symbol MDT. Medtronics stock was originally listed at a price of $26.25 in 1997. Medtronic closed at $89.31 in the latest trading session, marking a +0.48% move from the prior day. Investors will be hoping for strength from Medtronics as it approaches its next earnings release, which is expected to be May 25, 2023. Twenty analysts predict that Medtrony share price will fall in the coming year.

Stock Profile

"Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland."

Keywords

How much time have you spent trying to decide whether investing in Medtronic plc.? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Medtronic plc. are: Medtronic, Medtronics, hold, price, share, stock, company, and the most common words in the summary are: medtronic, stock, market, price, job, mdt, news, . One of the sentences in the summary was: holds shares valued at 517M.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #medtronic #stock #market #price #job #mdt #news.